Your browser doesn't support javascript.
loading
Impact of an intensive facility-community case management intervention on 6-month HIV outcomes among select key and priority populations in Uganda.
Meya, David B; Kiragga, Agnes N; Nalintya, Elizabeth; Banturaki, Grace; Akullo, Joan; Kalyesubula, Phillip; Sessazi, Patrick; Bitakalamire, Hillary; Kabanda, Joseph; Kalamya, Julius N; Namale, Alice; Bateganya, Moses; Kagaayi, Joseph; Gutreuter, Steve; Adler, Michelle R; Mitruka, Kiren.
Afiliação
  • Meya DB; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda. david.meya@gmail.com.
  • Kiragga AN; Department of Medicine and International Health, University of Minnesota, Minneapolis, MN, USA. david.meya@gmail.com.
  • Nalintya E; School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda. david.meya@gmail.com.
  • Banturaki G; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Akullo J; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Kalyesubula P; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Sessazi P; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Bitakalamire H; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Kabanda J; Infectious Diseases Institute, College of Health Sciences, Makerere University, Mulago Hill Road, 22418, Kampala, Uganda.
  • Kalamya JN; Kalangala District Health Services, Kalangala, Uganda.
  • Namale A; U.S Centers for Disease Control and Prevention, Kampala, Uganda.
  • Bateganya M; U.S Centers for Disease Control and Prevention, Kampala, Uganda.
  • Kagaayi J; U.S Centers for Disease Control and Prevention, Kampala, Uganda.
  • Gutreuter S; U.S Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Adler MR; Rakai Health Sciences, Program, Rakai, Uganda.
  • Mitruka K; Makerere School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda.
AIDS Res Ther ; 19(1): 62, 2022 12 05.
Article em En | MEDLINE | ID: mdl-36471321

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profissionais do Sexo Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Fármacos Anti-HIV / Profissionais do Sexo Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Africa Idioma: En Ano de publicação: 2022 Tipo de documento: Article